AlphaRx drug delivery, cancer news

AlphaRx announced it will establish an Asian headquarters in Hong Kong and a new R&D facility in Shanghai. The company said the move is part of its push into "greater" China and plans to develop cancer therapeutics using its nanoparticle technology at the Shanghai facility. The company said the change will not impact its North American headquarters. ...